Mai, Hai-Qiang
Chen, Qiu-Yan
Chen, Dongping
Hu, Chaosu
Yang, Kunyu
Wen, Jiyu
Li, Jingao
Shi, Ying-Rui
Jin, Feng
Xu, Ruilian
Pan, Jianji
Qu, Shenhong
Li, Ping
Hu, Chunhong
Liu, Yi-Chun
Jiang, Yi
He, Xia
Wang, Hung-Ming
Lim, Wan-Teck https://orcid.org/0000-0002-4655-0206
Liao, Wangjun
He, Xiaohui
Chen, Xiaozhong
Liu, Zhigang https://orcid.org/0000-0003-4043-3196
Yuan, Xianglin
Li, Qi
Lin, Xiaoyan
Jing, Shanghua
Chen, Yanju
Lu, Yin
Hsieh, Ching-Yun
Yang, Muh-Hwa https://orcid.org/0000-0002-8918-1244
Yen, Chia-Jui
Samol, Jens
Feng, Hui
Yao, Sheng
Keegan, Patricia https://orcid.org/0000-0002-7266-395X
Xu, Rui-Hua https://orcid.org/0000-0001-9771-8534
Article History
Received: 4 May 2021
Accepted: 21 June 2021
First Online: 2 August 2021
Change Date: 24 August 2026
Change Type: Update
Change Details: In the version of this article initially published, there were errors in Supplementary Table and the source data for Fig. . In Supplementary Table , the data were inadvertently duplicated from Supplementary Table . The <i>P</i> values in Supplementary Table were independently reformatted based on the correct irRECIST analysis to comply with the journal’s formatting requirements and were therefore correct. In the Fig. source data, the responder dataset for the JS001 group contained one extra patient entry corresponding to a patient whose best overall response was not evaluable. Fig. itself was generated using the correct data. We have therefore removed this patient from the source data. This correction affects only the submitted source data and does not affect the published figure, the study results, or the conclusions of the manuscript. The corrected Supplementary information and Source Data are now available online.
Change Date: 13 January 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41591-021-01673-3
Ethics
Competing interests: H.F. and S.Y. are employed by Shanghai Junshi Bioscience and TopAlliance Biosciences. P.K. is employed by TopAlliance Biosciences. R.-H.X. has served in consulting or advisory roles for Bristol-Myers Squibb, Merck Serono, Roche, Astellas and AstraZeneca. The remaining authors have no competing interests.